Clinical and research tests for 3105 - Genetic Testing Registry (GTR)

<< First< Prev

Page 1 of 3

Results: 1 to 20 of 42

Tests names and labs	Conditions	Genes, analytes, and microbes	Methods
Precision HealthPGx Panel (25 Genes) RPRD Diagnostics, LLC United States	97	23	D Deletion/duplication analysis T Targeted variant analysis
NeXT Dx Personalis, Inc. United States	1	413	I Microsatellite instability testing (MSI) R RNA analysis C Sequence analysis of the entire coding region
Whole Pharmacogenomics Scan RPRD Diagnostics, LLC United States	107	69	D Deletion/duplication analysis T Targeted variant analysis
RightMed Mental Health test OneOme, LLC United States	6	15	D Deletion/duplication analysis T Targeted variant analysis
Genomind Pharmacogenetic Report Genomind, Inc. Genomind, Inc United States	14	27	T Targeted variant analysis
GeneSight Psychotropic Assurex Health, Inc. United States	6	14	D Deletion/duplication analysis T Targeted variant analysis
Genetic study of pharmacogenetics HeartGenetics, Genetics and Biotechnology, SA Portugal	1	26	T Targeted variant analysis
Tempus nP Tempus AI United States	4	13	T Targeted variant analysis
Tempus xT Tempus AI United States	2	646	I Microsatellite instability testing (MSI) C Sequence analysis of the entire coding region
PGx-NP (Neuro-Psychiatry) SPMED CO., LTD Step forward Personalized Medicine South Korea	51	26	T Targeted variant analysis
PGx-Premium (Preemptive PGx test) SPMED CO., LTD Step forward Personalized Medicine South Korea	66	27	T Targeted variant analysis
PGx-SCAR (Hypersensitivity) SPMED CO., LTD Step forward Personalized Medicine South Korea	5	3	T Targeted variant analysis
OmniSeq INSIGHT OmniSeq, Inc. United States	1	525	R RNA analysis C Sequence analysis of the entire coding region
Hypersensitivity syndrome, carbamazepine-induced, susceptibility to, 608579 (Stevens-Johnson syndrome) (HLA-A gene) (Sequence Analysis-All Coding Exons) (Prenatal) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey	1	1	C Sequence analysis of the entire coding region
Hypersensitivity syndrome, carbamazepine-induced, susceptibility to, 608579 (Stevens-Johnson syndrome) (HLA-A gene) (Sequence Analysis-All Coding Exons) (Postnatal) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey	1	1	C Sequence analysis of the entire coding region
NGS HLA-A,B,C,DR,DQ,DP,DRB34 Allogen Laboratories-Cleveland Clinic United States	1	11	E Sequence analysis of select exons
ProvSeq 523 Providence St. Joseph Health Molecular Genomics Laboratory Providence St Joseph Health United States	1	523	C Sequence analysis of the entire coding region
OnkoSight Advanced Comprehensive Solid Tumor Panel (DNA/RNA) BioReference Health United States	1	523	C Sequence analysis of the entire coding region
OnkoSight Advanced 523 Gene NGS Panel BioReference Health United States	1	523	C Sequence analysis of the entire coding region
High Resolution HLA-A, B, C, DRB1, DQB1 Kashi Clinical Laboratories United States	2	5	E Sequence analysis of select exons

<< First< Prev

Page 1 of 3

Next >Last >>

Results: 1 to 20 of 42

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Filters

Test type

Test purpose

Test method

Molecular Genetics

Test service

Laboratory certification

Specimen type

Laboratory location

Other countries

Results: 1 to 20 of 42

Results: 1 to 20 of 42